Trade XOMA Corporation - XOMA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 29.09 |
| Open | 28.3 |
| 1-Year Change | 84.97% |
| Day's Range | 28.3 - 29.19 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 28.86 | 0.67 | 2.38% | 28.19 | 30.29 | 27.07 |
| Jul 24, 2024 | 28.05 | 0.59 | 2.15% | 27.46 | 28.93 | 27.20 |
| Jul 23, 2024 | 28.70 | 1.36 | 4.97% | 27.34 | 28.81 | 26.43 |
| Jul 22, 2024 | 28.37 | 1.25 | 4.61% | 27.12 | 28.47 | 27.06 |
| Jul 19, 2024 | 27.82 | 0.45 | 1.64% | 27.37 | 28.03 | 27.09 |
| Jul 18, 2024 | 27.21 | -0.55 | -1.98% | 27.76 | 28.84 | 26.69 |
| Jul 17, 2024 | 28.68 | 2.70 | 10.39% | 25.98 | 28.94 | 25.24 |
| Jul 16, 2024 | 26.95 | 1.10 | 4.26% | 25.85 | 26.96 | 25.85 |
| Jul 15, 2024 | 26.70 | 0.22 | 0.83% | 26.48 | 27.01 | 26.00 |
| Jul 12, 2024 | 26.91 | 1.41 | 5.53% | 25.50 | 26.94 | 25.50 |
| Jul 11, 2024 | 26.01 | 0.84 | 3.34% | 25.17 | 26.16 | 25.17 |
| Jul 10, 2024 | 25.25 | 1.28 | 5.34% | 23.97 | 25.67 | 23.97 |
| Jul 9, 2024 | 24.51 | 0.33 | 1.36% | 24.18 | 24.93 | 24.18 |
| Jul 8, 2024 | 24.18 | -0.85 | -3.40% | 25.03 | 25.64 | 24.15 |
| Jul 5, 2024 | 25.27 | 0.18 | 0.72% | 25.09 | 26.97 | 24.53 |
| Jul 3, 2024 | 25.68 | 1.07 | 4.35% | 24.61 | 25.77 | 23.75 |
| Jul 2, 2024 | 24.52 | 0.06 | 0.25% | 24.46 | 24.78 | 24.13 |
| Jul 1, 2024 | 24.87 | 2.07 | 9.08% | 22.80 | 25.12 | 22.62 |
| Jun 28, 2024 | 23.42 | 0.93 | 4.14% | 22.49 | 23.82 | 22.47 |
| Jun 27, 2024 | 22.12 | -0.86 | -3.74% | 22.98 | 23.35 | 21.97 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
XOMA Corporation Company profile
About XOMA Corp
XOMA Corporation (XOMA) is a biotechnology royalty aggregator. The Company's drug royalty aggregator business is focused on early to mid-stage clinical assets primarily in Phase I and II. XOMA acquires pre-commercial therapeutic candidates that are licensed to pharmaceutical or biotechnology companies. The Company's portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. The Company's royalty-aggregator business includes acquiring additional licenses to programs with third-party funding and has more than 70 assets. XOMA royalty portfolio includes NIS793, anti-transforming growth factor-beta (TGFb) antibody program; gevokizumab (VPM087); mezagitamab (TAK-079), iscalimab (CFZ533), and MK-4830.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, XOMA Corp revenues increased 30% to $38.2M. Net income applicable to common stockholders decreased 12% to $8M. Revenues reflect Europe segment increase of 40% to $35M, United States segment increase from $1.3M to $2.6M. Net income was offset by Stock-based Compensation in SGA increase of 56% to $6.2M (expense).
Equity composition
Common Stock $.0075 Par, 03/11, 46,666,666 auth., 29,510,963 issd. Insiders own 7.83%. PO: 4/91, 3.4M shs @ $26.50 by Alex. Brown& Sons. PO 6/01, 3M shs @ $15 by U.S. Bancorp Piper Jaffray. Series B Prfd. Stock $.05 Par, 8K auth., 2,959 issd. *1996, Co.'s 4% Conv. Subd. Debentures were conv. into 2M shs. of Common. 08/10, 1-for-15 reverse split.
| Industry: | Bio Therapeutic Drugs |
Suite 310
2200 Powell Street
EMERYVILLE
CALIFORNIA 94608
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com